Cargando…
Optimal alpha-1 antitrypsin level cutoffs for genotype identification in patients with chronic liver disease
Controversy exists whether alpha-1 antitrypsin (A1AT) genotype testing should be performed as a first-line screening for A1AT heterozygous variants. METHODS: We calculated the median and interquartile range of A1AT level for each genotype in 4378 patients with chronic liver disease and “miss rate” o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019232/ https://www.ncbi.nlm.nih.gov/pubmed/37133851 http://dx.doi.org/10.1097/HC9.0000000000000023 |